Published in Thorax on January 01, 2002
An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genomics (2008) 1.02
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC Cancer (2009) 0.86
Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients. Br J Clin Pharmacol (2013) 0.85
Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients. Sci Rep (2015) 0.82
Antiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cells. Biomed Res Int (2014) 0.80
Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles. Eur J Pharm Biopharm (2015) 0.79
Cancer imaging: is it cost-effective? Cancer Imaging (2004) 0.79
Pre-clinical drug prioritization via prognosis-guided genetic interaction networks. PLoS One (2010) 0.78
Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment. Am J Cancer Res (2016) 0.76
The role of dietary nutrition in stomach cancer. Contemp Oncol (Pozn) (2013) 0.76
Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer. Indian J Pharm Sci (2012) 0.76
A Novel, Potent, Small Molecule AKT Inhibitor Exhibits Efficacy against Lung Cancer Cells In Vitro. Cancer Res Treat (2015) 0.75
Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer. Thorax (2005) 0.75
PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells. Transl Oncol (2014) 0.75
A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells. Neoplasia (2016) 0.75
The lung cancer paradox: time for action. Thorax (2002) 0.75
Impact of anticancer drugs price cut on physician's prescription choices on first-line chemotherapy regimens and health expenditure for advanced non-small cell lung cancer in China. J Thorac Dis (2016) 0.75
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol (2000) 9.76
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet (1993) 6.08
Influences on the quality of published drug studies. Int J Technol Assess Health Care (1996) 2.83
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ (1998) 2.66
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol (1994) 2.66
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. Chest (1994) 2.32
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer. Br J Cancer (2000) 2.30
How should different life expectancies be valued? BMJ (1998) 2.10
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol (1998) 1.91
Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. J Clin Oncol (1990) 1.88
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (1999) 1.74
Palliative chemotherapy for advanced non-small cell lung cancer. BMJ (1994) 1.67
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Ann Oncol (1997) 1.61
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol (2000) 1.59
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst (1993) 1.59
Docetaxel. J Clin Oncol (1995) 1.58
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol (1998) 1.42
Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. J Natl Cancer Inst (2000) 1.33
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. J Clin Oncol (1996) 1.31
Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer. J Clin Oncol (1995) 1.31
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol (1999) 1.27
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol (2000) 1.22
Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. Br J Cancer (1989) 1.20
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study. J Clin Oncol (1997) 1.12
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol (1994) 1.04
Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales. Eur Respir J (1997) 0.94
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group. J Clin Oncol (1999) 0.92
Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer. J Natl Cancer Inst (2000) 0.91
Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptoms. Anticancer Drugs (1995) 0.90
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. J Clin Oncol (2000) 0.90
Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration. Chest (2000) 0.89
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer. Lung Cancer (1998) 0.87
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano. Br J Cancer (1996) 0.85
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532. Lung Cancer (2000) 0.85
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer. Lung Cancer (1999) 0.80
Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group. Ann Oncol (1996) 0.80
Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'. Lung Cancer (1996) 0.77
Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group. Semin Oncol (1996) 0.77
Managing patients with lung cancer. Guidelines must help bring us in line with European standards. BMJ (2000) 0.77
Observations on insulin: Part I. Chemical observations. Part II. Physiological assay. Biochem J (1929) 5.66
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29
Studies on heparin: Observations on the chemistry of heparin. Biochem J (1936) 4.40
Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess (2001) 4.31
Call to needle times after acute myocardial infarction in urban and rural areas in northeast Scotland: prospective observational study. BMJ (1998) 3.20
Cervical screening in Perth and Kinross since introduction of the new contract. BMJ (1991) 3.20
Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess (2010) 3.09
Nonsyndromic autosomal recessive deafness is linked to the DFNB1 locus in a large inbred Bedouin family from Israel. Am J Hum Genet (1995) 3.02
Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial. Br J Ophthalmol (2001) 2.98
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis. BMJ (1999) 2.66
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA (1999) 2.56
Thirty-year trends in incidence and age-distribution of prostate cancer in Kingston and St Andrew, Jamaica, 1978-2007. West Indian Med J (2011) 2.50
64-Slice computed tomography angiography in the diagnosis and assessment of coronary artery disease: systematic review and meta-analysis. Heart (2008) 2.42
Zinc content of bovine pancreas. Biochem J (1935) 2.34
How should different life expectancies be valued? BMJ (1998) 2.10
Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect Immun (2000) 1.86
Evaluation of a call programme for cervical cytology screening in women aged 50-60. BMJ (1989) 1.75
Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis (2011) 1.70
Localization of the Usher syndrome type ID gene (Ush1D) to chromosome 10. Hum Mol Genet (1996) 1.69
Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. Health Technol Assess (2003) 1.68
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess (2010) 1.67
The effectiveness of diagnostic tests for the assessment of shoulder pain due to soft tissue disorders: a systematic review. Health Technol Assess (2003) 1.67
Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess (2002) 1.61
Epidural analgesia compared with combined spinal-epidural analgesia during labor in nulliparous women. N Engl J Med (1997) 1.60
Genetic factors in congenital diaphragmatic hernia. Am J Hum Genet (2007) 1.58
Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease. Health Technol Assess (2008) 1.57
Walking a fine line. Physician inquiries into patients' religious and spiritual beliefs. Hastings Cent Rep (2003) 1.55
Intracellular Ca2+ storage in acidocalcisomes of Trypanosoma cruzi. Biochem J (1995) 1.54
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet (1994) 1.51
The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation. Health Technol Assess (2010) 1.51
TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology (2010) 1.49
The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health Technol Assess (2003) 1.47
Infections in cancer patients: some controversial issues. Support Care Cancer (1994) 1.46
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Neurologic changes during carotid endarterectomy under cervical block predict a high risk of postoperative stroke. Anesthesiology (1993) 1.44
Neurological damage resulting from extracorporeal shock wave lithotripsy when air is used to locate the epidural space. Anaesth Intensive Care (1993) 1.43
The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial. BJOG (2010) 1.42
Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin. Br J Dermatol (2013) 1.42
Prayer as therapy. A challenge to both religious belief and professional ethics. The Anglican Working Group in Bioethics. Hastings Cent Rep (2000) 1.42
Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess (2004) 1.42
Jamaica cancer mortality statistics, 1999. West Indian Med J (2002) 1.41
Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs. J Biol Chem (1999) 1.39
Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord (2003) 1.38
How complete can cervical screening be? The outcome of a call screening programme for women aged 20-60 years in Perth and Kinross. Cytopathology (1990) 1.37
IS1414, an Escherichia coli insertion sequence with a heat-stable enterotoxin gene embedded in a transposase-like gene. Infect Immun (2000) 1.34
Two frequent missense mutations in Pendred syndrome. Hum Mol Genet (1998) 1.31
An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg (2002) 1.28
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess (2004) 1.27
Neural correlates of working memory in Temporal Lobe Epilepsy--an fMRI study. Neuroimage (2012) 1.25
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technol Assess (2006) 1.24
Protein restriction for diabetic renal disease. Cochrane Database Syst Rev (2007) 1.23
Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet (2011) 1.20
Specialist nurses in diabetes mellitus. Cochrane Database Syst Rev (2003) 1.18
Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess (2007) 1.15
Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1993-1997. West Indian Med J (2001) 1.15
Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1998-2002. West Indian Med J (2008) 1.13
Characterization of a vacuolar pyrophosphatase in Trypanosoma brucei and its localization to acidocalcisomes. Mol Cell Biol (1999) 1.13
Presence of a vacuolar H+-pyrophosphatase in promastigotes of Leishmania donovani and its localization to a different compartment from the vacuolar H+-ATPase. Biochem J (1999) 1.13
Neuropsychologic testing within 18 hours after cardiac surgery. J Cardiothorac Vasc Anesth (2001) 1.12
Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 2003-2007. West Indian Med J (2010) 1.10
Could fewer islet cells be transplanted in type 1 diabetes? BMJ (2000) 1.09
Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) (1992) 1.09
Deletion 9q34.3 syndrome: genotype-phenotype correlations and an extended deletion in a patient with features of Opitz C trigonocephaly. J Med Genet (2005) 1.08
Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technol Assess (2012) 1.07
Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. Health Technol Assess (2005) 1.06
Endodontic recall radiographs: how reliable is our interpretation of endodontic success or failure and what factors affect our reliability? Oral Surg Oral Med Oral Pathol (1984) 1.05
Excess mortality, length of stay and cost attributable to candidaemia. J Infect (2009) 1.04
Cell death and birth in multiple sclerosis brain. J Neurol Sci (1997) 1.04
Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. Health Technol Assess (2000) 1.02
Vacuolar proton pyrophosphatase activity and pyrophosphate (PPi) in Toxoplasma gondii as possible chemotherapeutic targets. Biochem J (2000) 1.02
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technol Assess (2005) 1.01
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess (2011) 1.00
New gene for autosomal recessive non-syndromic hearing loss maps to either chromosome 3q or 19p. Am J Med Genet (1997) 1.00
Detection of cognitive decline after coronary surgery: a comparison of computerized and conventional tests. Br J Anaesth (2004) 0.98
5-HT activates neural reflexes regulating secretion in the guinea-pig colon. Neurogastroenterol Motil (1997) 0.98
Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus. Cochrane Database Syst Rev (2007) 0.98
Connexin mutations and hearing loss. Nature (1998) 0.98
Standardization of measurement of immunoglobulin-secreting cells in human peripheral circulation. Clin Diagn Lab Immunol (1997) 0.97
Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet (1997) 0.97
Rapid linear scale-up of a protein separation by centrifugal partition chromatography. J Chromatogr A (2008) 0.97
Gingival bleeding on probing increases after quitting smoking. J Clin Periodontol (2003) 0.97
Localization of a novel gene for nonsyndromic hearing loss (DFNB17) to chromosome region 7q31. Am J Med Genet (1998) 0.97
Cytomegalovirus infection, ascending myelitis, and pulmonary embolus. Ann Intern Med (1986) 0.96
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technol Assess (2001) 0.96
In vivo determination of multiple indices of periodontal inflammation by optical spectroscopy. J Periodontal Res (2008) 0.96
Regulation of cardiac mitochondrial calcium by average extramitochondrial calcium. Am J Physiol (1993) 0.96
Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian. Heart (1998) 0.96
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Health Technol Assess (2001) 0.95
Cloning and functional expression of a gene encoding a vacuolar-type proton-translocating pyrophosphatase from Trypanosoma cruzi. Biochem J (2000) 0.95
The value of digital imaging in diabetic retinopathy. Health Technol Assess (2003) 0.95
Distribution of motoneurones to the neck muscles, biventer cervicis, splenius and complexus in the cat. J Comp Neurol (1978) 0.95
Increased local matrix metalloproteinase-8 expression in the periodontal connective tissues of smokers with periodontal disease. Biochim Biophys Acta (2006) 0.95
Prenatal detection and outcome of congenital diaphragmatic hernia (CDH) associated with deletion of chromosome 15q26: two patients and review of the literature. Am J Med Genet A (2007) 0.94
Surgery for morbid obesity. Cochrane Database Syst Rev (2003) 0.94
Folate utilisation by Leishmania species and the identification of intracellular derivatives and folate-metabolising enzymes. Mol Biochem Parasitol (1987) 0.94
VACTERL Association Etiology: The Impact of de novo and Rare Copy Number Variations. Mol Syndromol (2013) 0.94